PTC Therapeutics Inc
PTCT
Market Cap$3.51B
Close$
$29.89
32.4% downside
Current Fair Value
32.4% downsideOvervalued by 32.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.51 Billion |
|---|---|
| Enterprise Value | $5.21 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.73 |
| Beta | 0.52 |
| Outstanding Shares | 77,201,783 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.4 |
|---|---|
| PEG | 47.49 |
| Price to Sales | 4.42 |
| Price to Book Ratio | -2.95 |
| Enterprise Value to Revenue | 6.2 |
| Enterprise Value to EBIT | -37.96 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | -2.26 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About PTC Therapeutics Inc
CEO: Stuart Peltz